253 related articles for article (PubMed ID: 19717648)
1. C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.
Pal R; Janz M; Galson DL; Gries M; Li S; Jöhrens K; Anagnostopoulos I; Dörken B; Mapara MY; Borghesi L; Kardava L; Roodman GD; Milcarek C; Lentzsch S
Blood; 2009 Oct; 114(18):3890-8. PubMed ID: 19717648
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Id2 expression by CCAAT/enhancer binding protein beta.
Karaya K; Mori S; Kimoto H; Shima Y; Tsuji Y; Kurooka H; Akira S; Yokota Y
Nucleic Acids Res; 2005; 33(6):1924-34. PubMed ID: 15809228
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
[TBL] [Abstract][Full Text] [Related]
4. Regulatory network of BLIMP1, IRF4, and XBP1 triad in plasmacytic differentiation and multiple myeloma pathogenesis.
Tang TF; Chan YT; Cheong HC; Cheok YY; Anuar NA; Looi CY; Gan GG; Wong WF
Cell Immunol; 2022 Oct; 380():104594. PubMed ID: 36081178
[TBL] [Abstract][Full Text] [Related]
5. Identification of C/EBPβ target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation.
Bonzheim I; Irmler M; Klier-Richter M; Steinhilber J; Anastasov N; Schäfer S; Adam P; Beckers J; Raffeld M; Fend F; Quintanilla-Martinez L
PLoS One; 2013; 8(5):e64544. PubMed ID: 23741337
[TBL] [Abstract][Full Text] [Related]
6. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
[TBL] [Abstract][Full Text] [Related]
7. IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.
Li S; Pal R; Monaghan SA; Schafer P; Ouyang H; Mapara M; Galson DL; Lentzsch S
Blood; 2011 May; 117(19):5157-65. PubMed ID: 21389327
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
10. C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.
Kim MH; Minton AZ; Agrawal V
Prostate; 2009 Sep; 69(13):1435-47. PubMed ID: 19489038
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
Liu M; Yuan T; Liu H; Chen P
Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I
Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238
[TBL] [Abstract][Full Text] [Related]
13. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals.
Rosati M; Valentin A; Patenaude DJ; Pavlakis GN
J Immunol; 2001 Aug; 167(3):1654-62. PubMed ID: 11466389
[TBL] [Abstract][Full Text] [Related]
14. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.
Borson ND; Lacy MQ; Wettstein PJ
Blood; 2002 Dec; 100(13):4629-39. PubMed ID: 12453881
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K
J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273
[TBL] [Abstract][Full Text] [Related]
16. IRF4 addiction in multiple myeloma.
Shaffer AL; Emre NC; Lamy L; Ngo VN; Wright G; Xiao W; Powell J; Dave S; Yu X; Zhao H; Zeng Y; Chen B; Epstein J; Staudt LM
Nature; 2008 Jul; 454(7201):226-31. PubMed ID: 18568025
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.
Yoshioka S; Miura Y; Yao H; Satake S; Hayashi Y; Tamura A; Hishita T; Ichinohe T; Hirai H; Takaor-Kondo A; Maekawa T
Stem Cells; 2014 Mar; 32(3):730-40. PubMed ID: 24115241
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.
Bristol JA; Morrison TE; Kenney SC
Mol Immunol; 2009 Aug; 46(13):2706-13. PubMed ID: 19523687
[TBL] [Abstract][Full Text] [Related]
19. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis.
Zhang JW; Klemm DJ; Vinson C; Lane MD
J Biol Chem; 2004 Feb; 279(6):4471-8. PubMed ID: 14593102
[TBL] [Abstract][Full Text] [Related]
20. Specific interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene.
Zhang F; Lin M; Abidi P; Thiel G; Liu J
J Biol Chem; 2003 Nov; 278(45):44246-54. PubMed ID: 12947119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
